Mapi Posters

2015. ISPOR European Congress – Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients with Chronic HCV in the Netherlands

Gaultney J, de Knegt J, Fassler P, Visser S, Johnson S. Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients with Chronic HCV in the Netherlands. Value Health. 18(7):A588. Presented at: ISPOR 18th Annual European Congress; November 10, 2015; Milan, Italy.